Detalhe da pesquisa
1.
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
Biomarkers
; 28(3): 313-322, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647745
2.
Management of early stage HER2 positive breast cancer and increased implementation of axillary imaging to improve identification of nodal metastasis.
J Surg Oncol
; 125(8): 1218-1223, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230701
3.
Clinical Applications of Circulating Tumor Cells in Breast Cancer.
Recent Results Cancer Res
; 215: 147-160, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31605228
4.
Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.
Ann Surg Oncol
; 26(5): 1214-1224, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680478
5.
Indications for prognostic gene expression profiling in early breast cancer.
Curr Treat Options Oncol
; 16(5): 23, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929335
6.
Breast cancer management in 2021: A primer for the obstetrics and gynecology.
Best Pract Res Clin Obstet Gynaecol
; 82: 30-45, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35307285
7.
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes.
JCI Insight
; 7(3)2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932500
8.
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial.
Clin Cancer Res
; 27(22): 6115-6123, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34521624
9.
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
PLoS One
; 16(11): e0260124, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780566
10.
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.
JAMA Oncol
; 7(4): 525-533, 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33630025
11.
Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
J Clin Oncol
; 40(32): 3673-3676, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767772
12.
Expanding the reach of HER2-targeted therapies: transformation of an historical paradigm.
J Clin Invest
; 132(24)2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519541
13.
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A.
JCO Oncol Pract
; 18(12): 830-832, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36122313
14.
Genomic analysis of adult B-ALL identifies potential markers of shorter survival.
Leuk Res
; 56: 44-51, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193567
15.
Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?-Reply.
JAMA Oncol
; 2021 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137801
16.
Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
Semin Oncol
; 43(5): 528-535, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27899183
17.
Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
JAMA Oncol
; 1(4): 542, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26181268